541 related articles for article (PubMed ID: 25958847)
21. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
[TBL] [Abstract][Full Text] [Related]
22. Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease.
A Mohamed D; S Abdelgayed S; A Essa H; S Mohamed R
Pak J Biol Sci; 2018 Jan; 21(9):454-462. PubMed ID: 30724047
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies.
Sharapova T; Devanarayan V; LeRoy B; Liguori MJ; Blomme E; Buck W; Maher J
Vet Pathol; 2016 Jan; 53(1):211-21. PubMed ID: 26123229
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
[TBL] [Abstract][Full Text] [Related]
25. Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.
Xu T; Zhou J; Zhu J; Zhang S; Zhang N; Zhao Y; Ding C; Shi X; Yao J
Metab Brain Dis; 2017 Apr; 32(2):483-491. PubMed ID: 27957651
[TBL] [Abstract][Full Text] [Related]
26. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
[TBL] [Abstract][Full Text] [Related]
27. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
[TBL] [Abstract][Full Text] [Related]
28. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
[TBL] [Abstract][Full Text] [Related]
29. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
[TBL] [Abstract][Full Text] [Related]
30. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat.
Song YS; Fang CH; So BI; Park JY; Jun DW; Kim KS
Ann Hepatol; 2013; 12(1):115-22. PubMed ID: 23293202
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
[TBL] [Abstract][Full Text] [Related]
33. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.
Liu XL; Cao HX; Wang BC; Xin FZ; Zhang RN; Zhou D; Yang RX; Zhao ZH; Pan Q; Fan JG
World J Gastroenterol; 2017 Dec; 23(46):8140-8151. PubMed ID: 29290651
[TBL] [Abstract][Full Text] [Related]
34. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.
Sakr HF; Abbas AM; Haidara MA
J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):61-71. PubMed ID: 29161233
[TBL] [Abstract][Full Text] [Related]
35. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
36. Study on the protection of water extracts of Polygoni Multiflori Radix and Polygoni Multiflori Radix Praeparata against NAFLD and its mechanism.
Lin L; Hao Z; Zhang S; Shi L; Lu B; Xu H; Ji L
J Ethnopharmacol; 2020 Apr; 252():112577. PubMed ID: 31953200
[TBL] [Abstract][Full Text] [Related]
37. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.
Zhang M; Yuan Y; Wang Q; Li X; Men J; Lin M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291215
[TBL] [Abstract][Full Text] [Related]
38. Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats.
Zheng H; Zhao J; Zheng Y; Wu J; Liu Y; Peng J; Hong Z
Mol Med Rep; 2014 Oct; 10(4):1758-64. PubMed ID: 25051256
[TBL] [Abstract][Full Text] [Related]
39. Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo study.
Liao N; Pan F; Wang Y; Zheng Y; Xu B; Chen W; Gao Y; Cai Z; Liu X; Liu J
Int J Mol Med; 2016 May; 37(5):1389-96. PubMed ID: 26986083
[TBL] [Abstract][Full Text] [Related]
40. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K
J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
